JMP Securities Reiterates Market Outperform Rating for Precigen (NASDAQ:PGEN)
Precigen (NASDAQ:PGEN – Get Free Report)‘s stock had its “market outperform” rating reissued by equities research analysts at JMP Securities in a report issued on Thursday,Benzinga reports. They currently have a $6.00 target price on the biotechnology company’s stock. JMP Securities’ price objective indicates a potential upside of 294.74% from the company’s previous close. A […]
Precigen (NASDAQ:PGEN – Get Free Report)‘s stock had its “market outperform” rating reissued by equities research analysts at JMP Securities in a report issued on Thursday,Benzinga reports. They currently have a $6.00 target price on the biotechnology company’s stock. JMP Securities’ price objective indicates a potential upside of 294.74% from the company’s previous close. A […]
